Compare · ACLS vs DHR
ACLS vs DHR
Side-by-side comparison of Axcelis Technologies Inc. (ACLS) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACLS operates in Technology, while DHR operates in Industrials - the two are in different parts of the market.
- DHR is the larger of the two at $151.82B, about 39.2x ACLS ($3.87B).
- DHR has been more active in the news (19 items in the past 4 weeks vs 5 for ACLS).
- DHR has more recent analyst coverage (25 ratings vs 18 for ACLS).
- Company
- Axcelis Technologies Inc.
- Danaher Corporation
- Price
- -
- -
- Market cap
- $3.87B
- $151.82B
- 1M return
- -2.22%
- -
- 1Y return
- +54.97%
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2000
- News (4w)
- 5
- 19
- Recent ratings
- 18
- 25
Axcelis Technologies Inc.
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest ACLS
- Axcelis Tech downgraded by Craig Hallum with a new price target
- SEC Form 10-Q filed by Axcelis Technologies Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Axcelis Technologies Inc.
- Axcelis Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Axcelis Announces Financial Results for Second Quarter 2026
- Axcelis Announces Participation in Upcoming Investor Conferences in August
- Axcelis Announces Successful Purion XEmax Eval Closure at Leading Semiconductor Foundry
- Axcelis Announces Timing and Availability of Second Quarter 2026 Results and Conference Call
- SVP Interim CFO Ryzhik David covered exercise/tax liability with 221 shares, decreasing direct ownership by 2% to 9,790 units (SEC Form 4) (tax liability)
- Amendment: SEC Form SCHEDULE 13G/A filed by Axcelis Technologies Inc.
Latest DHR
- President & CEO Blair Rainer sold $12,736,095 worth of shares (58,255 units at $218.63) (SEC Form 4)
- Executive Vice President Riley Christopher Paul was granted 41,072 shares, increasing direct ownership by 201% to 61,472 units (SEC Form 4)
- SEC Form 4 filed by EVP & Chief Financial Officer Gugino Matthew E
- SEC Form 4 filed by SVP-Chief Legal Officer Leiken Jonathan
- SVP, Chief Science Officer Gutierrez-Ramos Jose-Carlos was granted 13,477 shares, increasing direct ownership by 71% to 32,495 units (SEC Form 4)
- SEC Form 4 filed by Executive Vice President Sawyer Montgomery Julie A
- SEC Form 4 filed by VP, Chief Accounting Officer Bouda Christopher
- Executive Vice President Milosevich Gregory M was granted 15,402 shares, increasing direct ownership by 170% to 24,467 units (SEC Form 4)
- Chairman of Exec. Committee Rales Mitchell P was granted 500,000 shares, increasing direct ownership by 939% to 553,228 units (SEC Form 4)
- Chairman Rales Steven M was granted 500,000 shares, increasing direct ownership by 16% to 3,605,808 units (SEC Form 4)